NovaQuest Capital Management, L.L.C.

Holdings History for Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

Symbol: RVNC
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2020	10%	-18%	$5,431,000	216,038	-382,947	-64%	$25.14	Q3 2020
30 Jun 2020	17%	0%	$14,627,000	598,985	0		$24.42	Q2 2020
31 Mar 2020	25%	-40%	$8,865,000	598,985	-959,441	-62%	$14.80	Q1 2020
31 Dec 2019	32%	0%	$25,293,000	1,558,426	0		$16.23	Q4 2019
30 Sep 2019	53%	0%	$20,260,000	1,558,426	0		$13.00	Q3 2019
30 Jun 2019	39%	0%	$20,212,000	1,558,426	0		$12.97	Q2 2019
31 Mar 2019	23%	0%	$24,561,000	1,558,426	0		$15.76	Q1 2019
31 Dec 2018	35%	0%	$31,371,000	1,558,426	0		$20.13	Q4 2018
30 Sep 2018	55%	0%	$38,727,000	1,558,426	0		$24.85	Q3 2018
30 Jun 2018	61%	0%	$42,779,000	1,558,426	0		$27.45	Q2 2018
31 Mar 2018	66%	-65%	$48,000,000	1,558,426	-1,538,224	-50%	$30.80	Q1 2018
31 Dec 2017	88%	0%	$110,705,000	3,096,650	0		$35.75	Q4 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.